MRNA - Moderna, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - MRNA (1682852)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2026-06-15
MRNAHoge StephenPresS - Sale+OE$51.37-53,3361,639,897-3%-$2,739,870
D
2026-06-04
MRNAKlinger Shannon ThymeGCS - Sale+OE$50.00-3,47173,561-5%-$173,550
D
2026-05-21
MRNAAfeyan NoubarDirS - Sale+OE$46.84-9,2636,856,1640%-$433,879
D
2026-05-15
MRNAHoge StephenPresS - Sale+OE$48.40-53,3361,634,046-3%-$2,581,462
D
2026-05-01
MRNAHussain AbbasDirS - Sale+OE$46.63-5,68212,066-32%-$264,952
D
2026-03-02
MRNAKlinger Shannon ThymeGCS - Sale+OE$52.29-13,88559,689-19%-$726,047
D
2026-02-23
MRNAHoge StephenPresS - Sale+OE$48.84-160,0091,613,476-9%-$7,814,840

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top